SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma

Jinyuan Zhang1, Baojun Duan1,2, Fang Li1

  • 1Institute of Genetics and Development Biology, Translational Medcine Institute, Xi'an Jiaotong University, Xi'an 710301, China.

Insights

SET domain containing 7 (SETD7) promotes clear cell renal cell carcinoma (ccRCC) progression by methylating TAF7, stabilizing it, and increasing CCNA2 expression. This SETD7-TAF7-CCNA2 axis offers potential therapeutic targets for ccRCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • SET domain containing 7 (SETD7), a histone methyltransferase, shows abnormal expression in various cancers.
  • The role and mechanism of SETD7 in clear cell renal cell carcinoma (ccRCC) are not well understood.

Purpose of the Study:

  • To investigate the biological effects of the SETD7-TAF7-CCNA2 axis on ccRCC proliferation and metastasis.
  • To elucidate the molecular mechanism by which SETD7 influences ccRCC progression.

Main Methods:

  • Analysis of SETD7 and TAF7 expression and correlation in ccRCC tissues.
  • Investigation of SETD7's methylation of TAF7 at specific sites (K5, K300) and its effect on TAF7 stability.
  • Assessment of TAF7's role in regulating CCNA2 expression and its impact on ccRCC cell proliferation and migration.

Main Results:

  • SETD7 and TAF7 were upregulated in ccRCC and promoted cell proliferation and migration.
  • SETD7 directly methylates TAF7 at K5 and K300, leading to TAF7 deubiquitination and stabilization.
  • TAF7 transcriptionally activates CCNA2, and SETD7-mediated TAF7 methylation enhances this activity, promoting ccRCC.
  • Restoring TAF7 partially rescued the inhibitory effects of SETD7 knockdown on ccRCC cells.

Conclusions:

  • SETD7-mediated methylation of TAF7 is a key mechanism regulating CCNA2 transcription in ccRCC.
  • The SETD7-TAF7-CCNA2 axis plays a crucial role in ccRCC formation and progression.
  • Targeting the SETD7-TAF7-CCNA2 axis presents a potential therapeutic strategy for ccRCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K